Baxter International Inc. (BAX) Stock: A Closer Look at the Market Potential

ATHA

Company’s 36-month beta value is 0.63.Analysts have differing opinions on the stock, with 4 analysts rating it as a “buy,” 2 as “overweight,” 9 as “hold,” and 1 as “sell.”

The public float for BAX is 504.47M, and currently, short sellers hold a 1.62% ratio of that floaft. The average trading volume of BAX on April 09, 2024 was 3.74M shares.

BAX) stock’s latest price update

Baxter International Inc. (NYSE: BAX) has seen a decline in its stock price by -0.87 in relation to its previous close of 42.62. However, the company has experienced a -2.99% decline in its stock price over the last five trading sessions. Zacks Investment Research reported 2024-04-02 that Baxter’s (BAX) Novum IQ Infusion Platform is likely to help enhance patient safety and efficiency for clinicians following the FDA’s clearance.

BAX’s Market Performance

BAX’s stock has fallen by -2.99% in the past week, with a monthly drop of -2.85% and a quarterly rise of 7.89%. The volatility ratio for the week is 1.89% while the volatility levels for the last 30 days are 1.77% for Baxter International Inc. The simple moving average for the last 20 days is -0.53% for BAX stock, with a simple moving average of 6.05% for the last 200 days.

Analysts’ Opinion of BAX

Many brokerage firms have already submitted their reports for BAX stocks, with Morgan Stanley repeating the rating for BAX by listing it as a “Equal-Weight.” The predicted price for BAX in the upcoming period, according to Morgan Stanley is $45 based on the research report published on May 30, 2023 of the previous year 2023.

UBS, on the other hand, stated in their research note that they expect to see BAX reach a price target of $43. The rating they have provided for BAX stocks is “Neutral” according to the report published on March 29th, 2023.

Morgan Stanley gave a rating of “Equal-Weight” to BAX, setting the target price at $55 in the report published on January 06th of the previous year.

BAX Trading at 2.13% from the 50-Day Moving Average

After a stumble in the market that brought BAX to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -15.85% of loss for the given period.

Volatility was left at 1.77%, however, over the last 30 days, the volatility rate increased by 1.89%, as shares sank -3.47% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +8.36% upper at present.

During the last 5 trading sessions, BAX fell by -2.99%, which changed the moving average for the period of 200-days by -5.78% in comparison to the 20-day moving average, which settled at $42.40. In addition, Baxter International Inc. saw 9.29% in overturn over a single year, with a tendency to cut further gains.

Insider Trading

Reports are indicating that there were more than several insider trading activities at BAX starting from Mason Jeanne K, who sale 64,488 shares at the price of $40.61 back on Mar 01 ’24. After this action, Mason Jeanne K now owns 142,290 shares of Baxter International Inc., valued at $2,618,858 using the latest closing price.

Stock Fundamentals for BAX

Current profitability levels for the company are sitting at:

  • 0.01 for the present operating margin
  • 0.34 for the gross margin

The net margin for Baxter International Inc. stands at 0.18. The total capital return value is set at 0.01. Equity return is now at value -0.44, with -0.11 for asset returns.

Based on Baxter International Inc. (BAX), the company’s capital structure generated 0.63 points at debt to capital in total, while cash flow to debt ratio is standing at 0.12. The debt to equity ratio resting at 1.71. The interest coverage ratio of the stock is 0.26.

Currently, EBITDA for the company is 1.75 billion with net debt to EBITDA at 9.51. When we switch over and look at the enterprise to sales, we see a ratio of 2.18. The receivables turnover for the company is 5.45for trailing twelve months and the total asset turnover is 0.53. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.48.

Conclusion

In a nutshell, Baxter International Inc. (BAX) has experienced a mixed performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.

Most Popular

Related Posts